Safety and Immunogenicity of BPL-1357, A BPL-Inactivated, Whole-Virus, Universal Influenza Vaccine
Clinical trial NCT05027932 · COMPLETED
Trial details
- NCT number
- NCT05027932
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-27
- Primary completion
- 2023-06-13
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.